We are a clinical stage biopharmaceutical company aspiring to cure solid tumors with our novel TCR like CAR-T cell therapies that enhances the immune system with state of the art technology originated in prof. Hiroshi Shiku laboratory at Mie University.
We strongly believe that our uniquie TCR like CAR T-cell therapy is a quantum leap toward curing solid tumors, uncovered by modern CAR/TCR-T cell therapies.
Our proprietary TCR like CAR antibody is highly specific against target antigens (MAGEA4 and PRAME) in peptide-MHC complexes.
Moreover our proprietary signal domain constructs help to activate, maintain and prolong T cell effect in immunosuppressive tumor microenvironment.
We are proudly delivering this unique technology from prof. Hiroshi Shiku laboratory at Mie University to global medical practice.
Our Mission:
Lead to common CAR-T cell therapy for common cancers and common people
Our Values:
Bring value to the current and contribute to the next academic innovation
Meet expectations of medical practitioners for innovation
Always think of patients demanding such innovation
Company Details
- Employees
- 2
- Founded
- -
- Address
- Setagaya, Tokyo,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.tcellnouveau.com/
- Keywords
- CAR-T, TCR-T, CAR-T cell, CAR T Cell, immunotherapy, oncoimmunotherapy, oncology, cell therapy, cancer therapy, solid tumor, CAR-T cell therapy, neoantigen, MAGEA4, MAGE-A4, PRAME, NY-ESO-1, esophageal cancer, head and neck cancer, HLA02, cancer vaccine.
- HQ
- Tokyo
T Cell Nouveau Questions
T Cell Nouveau's website is https://www.tcellnouveau.com/
T Cell Nouveau's LinkedIn profile is https://jp.linkedin.com/company/t-cell-nouveau
T Cell Nouveau has
2 employees.
View email and phone details for 2
employees at T Cell Nouveau.
T Cell Nouveau's industry is
Biotechnology Research
T Cell Nouveau's top competitors are
S2s Japan,
Mie University,
Intage Group,
Link Therapeutics 株式会社,
Scad (Stem Cell & Device Laboratory, Inc. ),
Eneco Belgium,
Sibelga,
Reborna Biosciences, Inc.,
Baycurrent,
メドピア株式会社.
T Cell Nouveau's categories are Biotechnology Research
T Cell Nouveau's founding year is 2021
